Classical Hodgkin lymphoma (Q39066): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
O linfoma de Hodgkin clássico é um linfoma de células B caracterizado histologicamente pela presença de grandes células mononucleares de Hodgkin e células multinucleadas de Reed-Sternberg (HRS)._x000D_ Ocorre linfoproliferação monoclonal de células B na grande maioria dos casos. É caracterizado por uma distribuição bimodal de idade (15-30 anos de vida e idade avançada) e está frequentemente associado à infecção por EBV. Em menos de 5% dos casos, existe proliferação monoclonal de linfócitos T. Morfologicamente, é caracterizado pela presença de células de Reed-Sternberg e células de Hodgkin mononucleares. As células de Reed-Sternberg e Hodgkin mononucleares são CD30 positivas em quase todos os casos e CD15 positivas na maioria dos casos.
description / endescription / en
 
Classical Hodgkin lymphoma is a B-cell lymphoma characterised histologically by the presence of large mononuclear Hodgkin cells and multinucleated Reed-Sternberg (HRS) cells. A monoclonal B-cell lymphoproliferation in the vast majority of cases. It is characterised by a bimodal age distribution (15-30 years of life and late life) and is often associated with EBV infection. In less than 5% of cases it is a monoclonal proliferation of T-lymphocytes. Morphologically, it is characterised by the presence of Reed-Sternberg cells and mononuclear Hodgkin cells. The Reed-Sternberg and mononuclear Hodgkin cells are CD30 positive in nearly all cases and CD15 positive in the majority of cases.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1616050398 / rank
 
Normal rank
Property / CURIE
 
CID11:2B30.1
Property / CURIE: CID11:2B30.1 / rank
 
Normal rank
Property / Canary Token
 
dki-india-2B30.1
Property / Canary Token: dki-india-2B30.1 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: C81.7 / rank
 
Normal rank

Latest revision as of 04:22, 13 August 2026

Classical Hodgkin lymphoma is a B-cell lymphoma characterised histologically by the presence of large mononuclear Hodgkin cells and multinucleated Reed-Sternberg (HRS) cells. A monoclonal B-cell lymphoproliferation in the vast majority of cases. It is characterised by a bimodal age distribution (15-30 years of life and late life) and is often associated with EBV infection. In less than 5% of cases it is a monoclonal proliferation of T-lymphocytes. Morphologically, it is characterised by the presence of Reed-Sternberg cells and mononuclear Hodgkin cells. The Reed-Sternberg and mononuclear Hodgkin cells are CD30 positive in nearly all cases and CD15 positive in the majority of cases.
Language Label Description Also known as
default for all languages
2B30.1
    English
    Classical Hodgkin lymphoma
    Classical Hodgkin lymphoma is a B-cell lymphoma characterised histologically by the presence of large mononuclear Hodgkin cells and multinucleated Reed-Sternberg (HRS) cells. A monoclonal B-cell lymphoproliferation in the vast majority of cases. It is characterised by a bimodal age distribution (15-30 years of life and late life) and is often associated with EBV infection. In less than 5% of cases it is a monoclonal proliferation of T-lymphocytes. Morphologically, it is characterised by the presence of Reed-Sternberg cells and mononuclear Hodgkin cells. The Reed-Sternberg and mononuclear Hodgkin cells are CD30 positive in nearly all cases and CD15 positive in the majority of cases.

      Statements

      CID11:2B30.1
      0 references
      dki-india-2B30.1
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references